David Ledieu

622 total citations
16 papers, 277 citations indexed

About

David Ledieu is a scholar working on Hematology, Immunology and Small Animals. According to data from OpenAlex, David Ledieu has authored 16 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Immunology and 4 papers in Small Animals. Recurrent topics in David Ledieu's work include Immunotoxicology and immune responses (4 papers), Animal testing and alternatives (4 papers) and Platelet Disorders and Treatments (3 papers). David Ledieu is often cited by papers focused on Immunotoxicology and immune responses (4 papers), Animal testing and alternatives (4 papers) and Platelet Disorders and Treatments (3 papers). David Ledieu collaborates with scholars based in Switzerland, United States and United Kingdom. David Ledieu's co-authors include Serge Côté, Mark J. Graham, Michal Magid-Slav, Dana B. Walker, Laura Boone, Daniela Ennulat, Martina Stirn, Armin Wolf, Daniel Roth and François Pognan and has published in prestigious journals such as Toxicology and Applied Pharmacology, Archives of Toxicology and Toxicologic Pathology.

In The Last Decade

David Ledieu

16 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Ledieu Switzerland 9 81 72 52 39 38 16 277
Zeynep Karaali Türkiye 12 85 1.0× 19 0.3× 41 0.8× 7 0.2× 26 0.7× 28 343
Alia Albawardi United Arab Emirates 11 132 1.6× 32 0.4× 32 0.6× 4 0.1× 26 0.7× 38 447
Kyoko Furuta Japan 11 80 1.0× 23 0.3× 31 0.6× 6 0.2× 31 0.8× 20 370
Alexander Weymann United States 10 144 1.8× 18 0.3× 63 1.2× 3 0.1× 38 1.0× 13 527
Lingwei Jin China 12 150 1.9× 14 0.2× 26 0.5× 3 0.1× 21 0.6× 21 402
Rachel Sparks United States 9 183 2.3× 20 0.3× 54 1.0× 3 0.1× 21 0.6× 11 506
Lijun Ma China 6 155 1.9× 46 0.6× 137 2.6× 2 0.1× 40 1.1× 7 487
Aydın Güçlü Türkiye 12 92 1.1× 9 0.1× 80 1.5× 3 0.1× 68 1.8× 20 357
H. Y. Pan China 7 64 0.8× 13 0.2× 21 0.4× 3 0.1× 39 1.0× 16 334
Lilian McGregor France 11 76 0.9× 175 2.4× 51 1.0× 3 0.1× 25 0.7× 15 367

Countries citing papers authored by David Ledieu

Since Specialization
Citations

This map shows the geographic impact of David Ledieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ledieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ledieu more than expected).

Fields of papers citing papers by David Ledieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ledieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ledieu. The network helps show where David Ledieu may publish in the future.

Co-authorship network of co-authors of David Ledieu

This figure shows the co-authorship network connecting the top 25 collaborators of David Ledieu. A scholar is included among the top collaborators of David Ledieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ledieu. David Ledieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ledieu, David & Serge Côté. (2019). Methods for measurement of platelet function in the assessment of nonclinical drug safety and implications for translatability. Current Opinion in Toxicology. 17. 31–40. 2 indexed citations
2.
Pognan, François, Maria Papoutsi, David Ledieu, et al.. (2018). Induction of hemangiosarcoma in mice after chronic treatment with S1P-modulator siponimod and its lack of relevance to rat and human. Archives of Toxicology. 92(5). 1877–1891. 3 indexed citations
3.
Côté, Serge, et al.. (2017). A combined approach to early detect in vitro drug-induced hemostatic changes in preclinical safety. Experimental and Toxicologic Pathology. 69(5). 275–283. 2 indexed citations
4.
Benjamin, Amanda, David J. Gallacher, Andrea Greiter‐Wilke, et al.. (2015). Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies. Journal of Pharmacological and Toxicological Methods. 75. 101–110. 4 indexed citations
5.
Bauer, Natali, Thaqif El Khassawna, Martina Stirn, et al.. (2015). Characterization of bone turnover and energy metabolism in a rat model of primary and secondary osteoporosis. Experimental and Toxicologic Pathology. 67(4). 287–296. 8 indexed citations
6.
Schümann, Jens, Armelle Grevot, David Ledieu, et al.. (2015). Reduced Activity of Sphingosine-1-Phosphate Lyase Induces Podocyte-related Glomerular Proteinuria, Skin Irritation, and Platelet Activation. Toxicologic Pathology. 43(5). 694–703. 35 indexed citations
7.
Côté, Serge, et al.. (2012). Optimization of Multiplate® whole blood platelet aggregometry in the Beagle dog and Wistar rat for ex vivo drug toxicity testing. Experimental and Toxicologic Pathology. 65(5). 637–644. 27 indexed citations
8.
Bolon, Brad, Erio Barale-Thomas, Alys Bradley, et al.. (2010). International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies. Experimental and Toxicologic Pathology. 63(1-2). 187–195. 4 indexed citations
9.
Wolf, Armin, Philippe Couttet, Min Dong, et al.. (2010). Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies. Leukemia Research. 34(9). 1180–1188. 58 indexed citations
10.
Wolf, Armin, Philippe Couttet, Min Dong, et al.. (2010). Preclinical evaluation of potential nilotinib cardiotoxicity. Leukemia Research. 35(5). 631–637. 16 indexed citations
11.
Ennulat, Daniela, Dana B. Walker, Michal Magid-Slav, et al.. (2010). Effects of Hepatic Drug-metabolizing Enzyme Induction on Clinical Pathology Parameters in Animals and Man. Toxicologic Pathology. 38(5). 810–828. 63 indexed citations
12.
Bolon, Brad, Erio Barale-Thomas, Alys Bradley, et al.. (2010). International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-Type, Nonclinical Toxicity Studies. Journal of Toxicologic Pathology. 23(3). 171–181. 7 indexed citations
13.
Bolon, Brad, Erio Barale-Thomas, Alys Bradley, et al.. (2010). International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-type, Nonclinical Toxicity Studies. Toxicologic Pathology. 38(6). 984–992. 11 indexed citations
14.
Roth, Daniel, et al.. (2010). Sublingual and submandibular blood collection in mice: a comparison of effects on body weight, food consumption and tissue damage. Laboratory Animals. 44(4). 352–358. 19 indexed citations
15.
Ledieu, David, et al.. (2008). Detection of reticulated platelets in whole blood of rats using flow cytometry. Experimental and Toxicologic Pathology. 60(6). 443–448. 3 indexed citations
16.
Pawlowski, Valérie, Ghislaine Guigon, David Ledieu, et al.. (2006). Altered gene expression in rat mesenteric tissue following in vivo exposure to a phosphodiesterase 4 inhibitor. Toxicology and Applied Pharmacology. 218(1). 52–63. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026